Format

Send to

Choose Destination
Vet Clin North Am Small Anim Pract. 2001 Sep;31(5):1005-14, viii.

Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).

Author information

1
Division of Endocrinology, Bobst Hospital, Caspary Research Institute, Animal Medical Center, New York, New York, USA.

Abstract

Pituitary-dependent hyperadrenocorticism (Cushing's disease) is a relatively common endocrine disorder of middle- to old-age dogs. Three treatments commonly used in the management of pituitary-dependent Cushing's disease in dogs include mitotane, ketoconazole, and L-deprenyl. These medications are associated with the potential of different side effects and expense, but all can produce satisfactory results in dogs with this disease. The choice of treatment for a given dog depends on the severity of the dog's disease, as well as clinician and client preferences. This article reviews the indications and adverse effects associated with each of these three drugs, as well as the treatment protocols commonly used in treating dogs with hyperadrenocorticism.

PMID:
11570123
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center